@col69 if they marketed their product wide reaching with resources they would be willing to deploy for Vivagel. That would be comforting indeed, I’m not sure how to get that information but it would be welcome indeed. Sales figures would be a good indication however that would probably require an annual report.
Not so good deal, page-8
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 65000 | 1 |
View Market Depth
| Last trade - 16.12pm 25/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable